SERPINE2 and metastatic neoplasm: SERPINE2 is overexpressed in a large number of invasive/metastatic tumors including breast, prostate, pancreatic, colorectal, oral-squamous, and testicular cancers and is required for tumor growth and malignant progression [6, 10].